Pioneering a new era in cancer diagnostics
Roche is pioneering a new era in cancer diagnostics to address the most life-threatening of cancers.
Innovative technologies such as next-generation sequencing (NGS) and liquid biopsies are transforming oncology across the care continuum, facilitating the evolution of personalised healthcare to its ultimate objective: patients receiving treatment tailored specially for their disease.
Roche is exploring scientific and technological advances and their application in oncology, as well as in other areas such as pre-natal testing and in infectious disease. Liquid biopsies for diseases such as lung cancer promise a less invasive and more responsive approach to patient care informed by closer and more convenient monitoring of the disease.
Click on the items below for more information on these cutting-edge advances in diagnostics.